1-7 of 7
Margaret M. Briehl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma

Clinical Trials & Observations
Paul M. Barr, Thomas P. Miller, Jonathan W. Friedberg, Derick R. Peterson, Andrea M. Baran, Megan Herr, Catherine M. Spier, Haiyan Cui, Denise J. Roe, Daniel O. Persky, Carla Casulo, Jamie Littleton, Mark Schwartz, Soham Puvvada, Terry H. Landowski, Lisa M. Rimsza, Robert T. Dorr, Richard I. Fisher, Steven H. Bernstein, Margaret M. Briehl
Journal: Blood
Blood (2014) 124 (8): 1259–1265.
https://doi.org/10.1182/blood-2014-04-570044
Published: 2014
Journal Articles

Redox Associated Gene Expression Predicts For Responses To The Pro-Oxidant Molecule Imexon In Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma: Results Of a Multi-Center Phase II Study

Paul M. Barr, MD, Margaret M. Briehl, PhD, Steven H Bernstein, MD, Jonathan W. Friedberg, MD, Andrea Baran, MS, Derick R. Peterson, PhD, Daniel Oscar Persky, MD, Carla Casulo, MD, Megan M. Herr, BS, Jamie Littleton, BSN, Erin Cebula, MPH, CCRP, Mark Schwartz, PhD, Soham D. Puvvada, MD, Robert T Dorr, PhD, Richard I Fisher, MD, Thomas P. Miller, MD
Journal: Blood
Blood (2013) 122 (21): 89.
https://doi.org/10.1182/blood.V122.21.89.89
Published: 2013
Journal Articles

Genetic Polymorphisms In Oxidative Stress-Related Genes Correlated with Outcome Following Anthracycline-Based Therapy for Aggressive B-Cell Non-Hodgkin Lymphomas

Heather L. Tardif, Song Yao, PhD, Bryan H. Goldman, MS, Catherine M. Spier, MD, Michael L. LeBlanc, PhD, Lisa M. Rimsza, MD, Daniel O. Persky, MD, Thomas P. Miller, MD, Richard I Fisher, MD, Christine B. Ambrosone, PhD, Margaret M. Briehl, PhD
Journal: Blood
Blood (2010) 116 (21): 321.
https://doi.org/10.1182/blood.V116.21.321.321
Published: 2010
Journal Articles

Modulation of Cell Surface Protein Free Thiols; A Potential Novel Mechanism of Action of the Sesquiterpene Lactone Parthenolide in Non-Hodgkin's Lymphoma.

Jolanta Skalska, PhD, Paul S Brookes, PhD, S. M Nadtochy, Shannon Hilchey, PhD, Craig T. Jordan, PhD, Monica L. Guzman, PhD, Sanjay Maggirwar, PhD, Margaret M Briehl, PhD, Steven H. Bernstein, MD
Journal: Blood
Blood (2009) 114 (22): 3774.
https://doi.org/10.1182/blood.V114.22.3774.3774
Published: 2009
Journal Articles

Induced Major Histocompatibility Class II (MHCII) Expression Does Not Alter Chemosensitivity, Radiosensitivity, Redox Potential, or Proliferation Rate in a CIITA-Transfected Diffuse Large B Cell Lymphoma (DLBCL) Cell Line.

Betty J. Glinsmann-Gibson, MS, Kelly A. Cycon, Shawn P. Murphy, Ph.D., Thomas P. Miller, M.D., Thomas M. Grogan, M.D., Margaret E. Tome, Ph.D., Margaret M. Briehl, Ph.D., Lisa M. Rimsza, MD
Journal: Blood
Blood (2006) 108 (11): 2040.
https://doi.org/10.1182/blood.V108.11.2040.2040
Published: 2006
Journal Articles

A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis

Clinical Trials & Observations
Margaret E. Tome, David B. F. Johnson, Lisa M. Rimsza, Robin A. Roberts, Thomas M. Grogan, Thomas P. Miller, Larry W. Oberley, Margaret M. Briehl
Journal: Blood
Blood (2005) 106 (10): 3594–3601.
https://doi.org/10.1182/blood-2005-02-0487
Published: 2005
Journal Articles

Induction of mitochondrial changes in myeloma cells by imexon

Katerina Dvorakova, Caroline N. Waltmire, Claire M. Payne, Margaret E. Tome, Margaret M. Briehl, Robert T. Dorr
Journal: Blood
Blood (2001) 97 (11): 3544–3551.
https://doi.org/10.1182/blood.V97.11.3544
Published: 2001